Chordia Therapeutics Inc. (TYO:190A)
Japan · Delayed Price · Currency is JPY 50.00
0.00 (0.00%)
Oct 26, 2026, 3:30 PM JST
Chordia Therapeutics Market Cap
Chordia Therapeutics has a market cap or net worth of 3.87 billion as of October 26, 2026. It is the 35,480th most valuable company in the world and the 3,297th biggest in Japan. Its market cap has decreased by 51.67% in one year.
Market Cap
3.87B
Enterprise Value
1.82B
Revenue
n/a
Global Rank
Country Rank
#3,297 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since June 14, 2024, Chordia Therapeutics's market cap has decreased from 12.58B to 3.87B, a decrease of -69.26%. That is a compound annual growth rate of -39.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 3.87B | -48.09% |
| Dec 30, 2025 | 7.45B | -65.16% |
| Dec 30, 2024 | 21.39B | 69.94% |
| Jun 14, 2024 | 12.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cyfuse Biomedical K.K. | 5.67B |
| BrightPath Biotherapeutics | 5.42B |
| Kringle Pharma | 5.12B |
| PRISM BioLab Co.,LTD | 4.88B |
| Kohjin Bio | 3.92B |
| Noile-Immune Biotech | 3.82B |
| Ribomic | 3.73B |
| D. Western Therapeutics Institute | 3.68B |